Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to observe the tolerability and effectiveness of Kaletra in Human Immunodeficiency Virus/Hepatitis-B Virus and Human Immunodeficiency Virus/Hepatitis-C Virus co-infected patients.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01153269
Study type Observational
Source Abbott
Contact
Status Completed
Phase N/A
Start date May 2001
Completion date November 2010